Effect of Retrievable Stent Size on Endovascular Treatment of Acute Ischemic Stroke: A Multicenter Study

REFERENCES

1. 1.↵
   2. Smith WS,
   3. Lev MH,
   4. English JD, et al

   . Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA. Stroke 2009;40:3834–40 doi:10.1161/STROKEAHA.109.561787 pmid:19834014

   Abstract/FREE Full Text
2. 2.↵
   2. Saver JL,
   3. Goyal M,
   4. Bonafe A, et al

   ; SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015;372:2285–95 doi:10.1056/NEJMoa1415061 pmid:25882376

   CrossRefPubMed
3. 3.↵
   2. Jovin TG,
   3. Chamorro A,
   4. Cobo E, et al

   ; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015;372:2296–306 doi:10.1056/NEJMoa1503780 pmid:25882510

   CrossRefPubMed
4. 4.↵
   2. Goyal M,
   3. Demchuk AM,
   4. Menon BK, et al

   ; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015;372:1019–30 doi:10.1056/NEJMoa1414905 pmid:25671798

   CrossRefPubMed
5. 5.↵
   2. Campbell BC,
   3. Mitchell PJ,
   4. Kleinig TJ, et al

   ; EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015;372:1009–18 doi:10.1056/NEJMoa1414792 pmid:25671797

   CrossRefPubMed
6. 6.↵
   2. Berkhemer OA,
   3. Fransen PS,
   4. Beumer D, et al

   . A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015;372:11–20 doi:10.1056/NEJMoa1411587 pmid:25517348

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Bracard S,
   3. Ducrocq X,
   4. Mas JL, et al

   ; THRACE investigators. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol 2016;15:1138–47 doi:10.1016/S1474-4422(16)30177-6 pmid:27567239

   CrossRefPubMed
8. 8.↵
   2. Saver JL,
   3. Jahan R,
   4. Levy EI, et al

   ; SWIFT Trialists. Solitaire flow restoration device versus the Merci retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012;380:1241–49 doi:10.1016/S0140-6736(12)61384-1 pmid:22932715

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Nogueira RG,
   3. Lutsep HL,
   4. Gupta R, et al

   ; TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012;380:1231–40 doi:10.1016/S0140-6736(12)61299-9 pmid:22932714

   CrossRefPubMedWeb of Science
10. 10.↵
    2. Papanagiotou P,
    3. Roth C,
    4. Walter S, et al

    . Treatment of acute cerebral artery occlusion with a fully recoverable intracranial stent: a new technique. Circulation 2010;121:2605–06 doi:10.1161/CIRCULATIONAHA.110.948166 pmid:20547941

    FREE Full Text
11. 11.↵
    2. Almekhlafi MA,
    3. Menon BK,
    4. Freiheit EA, et al

    . A meta-analysis of observational intra-arterial stroke therapy studies using the Merci device, Penumbra system, and retrievable stents. AJNR Am J Neuroradiol 2013;34:140–45 doi:10.3174/ajnr.A3276 pmid:22837311

    Abstract/FREE Full Text
12. 12.↵
    2. Henkes H,
    3. Flesser A,
    4. Brew S, et al

    . A novel microcatheter-delivered, highly-flexible and fully-retrievable stent, specifically designed for intracranial use: technical note. Interv Neuroradiol 2003;9:391–93 doi:10.1177/159101990300900411 pmid:20591320

    CrossRefPubMed
13. 13.↵
    2. Broussalis E,
    3. Trinka E,
    4. Hitzl W, et al

    . Comparison of stent-retriever devices versus the Merci retriever for endovascular treatment of acute stroke. AJNR Am J Neuroradiol 2013;34:366–72 doi:10.3174/ajnr.A3195 pmid:22790249

    Abstract/FREE Full Text
14. 14.↵
    2. Gill R,
    3. Schneck MJ

    . The use of stent retrievers in acute ischemic stroke. Expert Rev Neurother 2016;16:969–81 doi:10.1080/14737175.2016.1193007 pmid:27219051

    CrossRefPubMed
15. 15.↵
    2. Schmidt W,
    3. Wissgott C,
    4. Andresen R, et al

    . Performance characteristics of modern self-expanding nitinol stents indicated for SFA. Rofo 2011;183:818–25 doi:10.1055/s-0031-1273445 pmid:21751121

    CrossRefPubMed
16. 16.↵
    2. Voûte MT,
    3. Hendriks JM,
    4. van Laanen JH, et al

    . Radial force measurements in carotid stents: influence of stent design and length of the lesion. J Vasc Intervt Radiol 2011;22:661–66 doi:10.1016/j.jvir.2011.01.450 pmid:21514520

    CrossRefPubMed
17. 17.↵
    2. Matsumoto T,
    3. Inoue K,
    4. Tanaka S, et al

    . Radial forces of stents used in thoracic endovascular aortic repair and bare self-expanding nitinol stents measured ex vivo: rapid rescue for obstruction of the innominate artery using bare self-expanding nitinol stents. Vascular 2017;25:36–41 doi:10.1177/1708538116640131 pmid:26993143

    CrossRefPubMed
18. 18.↵
    2. Bosiers M,
    3. de Donato G,
    4. Deloose K, et al

    . Does free cell area influence the outcome in carotid artery stenting? Eur J Vasc Endovasc Surg 2007;33:135–41; discussion 142–43 doi:10.1016/j.ejvs.2006.09.019 pmid:17097897

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Zhou Z,
    3. Yin Q,
    4. Xu G, et al

    . Influence of vessel size and tortuosity on in-stent restenosis after stent implantation in the vertebral artery ostium. Cardiovasc Intervent Radiol 2011;34:481–87 doi:10.1007/s00270-010-9953-4 pmid:20683721

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Csobay-Novak C,
    3. Bárány T,
    4. Zima E, et al

    . Role of stent selection in the incidence of persisting hemodynamic depression after carotid artery stenting. J Endovasc Ther 2015;22:122–29 doi:10.1177/1526602814566404 pmid:25775692

    CrossRefPubMed
21. 21.↵
    2. Hur SH,
    3. Won KB,
    4. Kim IC, et al

    ; DIAMOND investigators. Comparison of 2-year clinical outcomes between diabetic versus nondiabetic patients with acute myocardial infarction after 1-month stabilization: analysis of the prospective registry of DIAMOND (DIabetic Acute Myocardial infarctiON Disease) in Korea: an observational registry study. Medicine 2016;95:e3882 doi:10.1097/MD.0000000000003882 pmid:27336875

    CrossRefPubMed
22. 22.↵
    2. Kitahara H,
    3. Okada K,
    4. Kobayashi Y, et al

    . TCT-555 impact of stent size selection on acute and long-term outcomes after drug-eluting stent implantation in de novo coronary lesions. J Am Col Cardiol 2015;66:B225 doi:10.1016/j.jacc.2015.08.1025

    CrossRef
23. 23.↵
    2. von Kummer R,
    3. Broderick JP,
    4. Campbell BC, et al

    . The Heidelberg Bleeding Classification: classification of bleeding events after ischemic stroke and reperfusion therapy. Stroke 2015;46:2981–86 doi:10.1161/STROKEAHA.115.010049 pmid:26330447

    FREE Full Text
24. 24.↵
    2. Saver JL,
    3. Goyal M,
    4. van der Lugt A, et al

    ; HERMES Collaborators. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA 2016;316:1279 doi:10.1001/jama.2016.13647 pmid:27673305

    CrossRefPubMed
25. 25.↵
    2. Sun CH,
    3. Ribo M,
    4. Goyal M, et al

    . Door-to-puncture: a practical metric for capturing and enhancing system processes associated with endovascular stroke care, preliminary results from the rapid reperfusion registry. J Am Heart Assoc 2014;3:e000859 doi:10.1161/JAHA.114.000859 pmid:24772523

    Abstract/FREE Full Text
26. 26.↵
    2. Mehta BP,
    3. Leslie-Mazwi TM,
    4. Chandra RV, et al

    . Reducing door-to-puncture times for intra-arterial stroke therapy: a pilot quality improvement project. J Am Heart Assoc 2014;3:e000963 doi:10.1161/JAHA.114.000963 pmid:25389281

    Abstract/FREE Full Text
27. 27.↵
    2. Kang DH,
    3. Kim YW,
    4. Hwang YH, et al

    . Instant reocclusion following mechanical thrombectomy of in situ thromboocclusion and the role of low-dose intra-arterial tirofiban. Cerebrovasc Dis 2014;37:350–55 doi:10.1159/000362435 pmid:24941966

    CrossRefPubMed
28. 28.↵
    2. Loh Y,
    3. Jahan R,
    4. McArthur DL, et al

    . Recanalization rates decrease with increasing thrombectomy attempts. AJNR Am J Neuroradiol 2010;31:935–39 doi:10.3174/ajnr.A1958 pmid:20075091

    Abstract/FREE Full Text
29. 29.↵
    2. Angermaier A,
    3. Michel P,
    4. Khaw AV, et al

    . Intravenous thrombolysis and passes of thrombectomy as predictors for endovascular revascularization in ischemic stroke. J Stroke Cerebrovasc Dis 2016;25:2488–95 doi:10.1016/j.jstrokecerebrovasdis.2016.06.024 pmid:27495833

    CrossRefPubMed
30. 30.↵
    2. Gröschel K,
    3. Schnaudigel S,
    4. Ernemann U, et al

    . Size matters! Stent-length is associated with thrombembolic complications after carotid artery stenting. Stroke 2008;39:e131–32; author reply e133 doi:10.1161/STROKEAHA.108.522219 pmid:18583551

    FREE Full Text
31. 31.↵
    2. Lee JS,
    3. Hong JM,
    4. Lee KS, et al

    . Endovascular therapy of cerebral arterial occlusions: intracranial atherosclerosis versus embolism. J Stroke Cerebrovasc Dis 2015;24:2074–80 doi:10.1016/j.jstrokecerebrovasdis.2015.05.003 pmid:26163890

    CrossRefPubMed
32. 32.↵
    2. Wong L

    . Global burden of intracranial atherosclerosis. Int J Stroke 2006;1:158–59 doi:10.1111/j.1747-4949.2006.00045.x pmid:18706036

    CrossRefPubMedWeb of Science
33. 33.↵
    2. Sacco RL,
    3. Kargman DE,
    4. Gu Q, et al

    . Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: the Northern Manhattan Stroke Study. Stroke 1995;26:14–20 doi:10.1161/01.STR.26.1.14 pmid:7839388

    Abstract/FREE Full Text
34. 34.↵
    2. Baek S,
    3. Park SH,
    4. Won E, et al

    . Propensity score matching: a conceptual review for radiology researchers. Korean J Radiology 2015;16:286–96 doi:10.3348/kjr.2015.16.2.286 pmid:25741190

    CrossRefPubMed